Prostate cancer
Conditions
Interventions
Sponsors
Department of Urology Laboratory, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Patients who are diagnosised of prostate cancer by biopsy, and progressed to castration-resistant prostate cancer patients after treatment; (2) Patients who agreeing to receive standard second-line hormonal therapy without other antineoplastic treatment; (3) Patient who agreeing to undergo second needle biopsies.
Exclusion criteria
Exclusion criteria: (1) Patient who has serious heart,lung,liver or kidney disease; (2) Patient who refusing to accept second-line hormonal therapy; (3) Patient who failed to regulate second-line hormonal therapy with the orders requirements; (4) In addition to second-line hormonal therapy,patient who undergoing surgery,chemotherapy or radiation therapy; (5) Patient who refusing to undergo second needle biopsies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AR-V7 Prostate specific antigen; | — |
Countries
China
Contacts
Public ContactYe Zhangqun
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed